The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
MF Osuchowski, MS Winkler, T Skirecki… - The Lancet …, 2021 - thelancet.com
The zoonotic SARS-CoV-2 virus that causes COVID-19 continues to spread worldwide, with
devastating consequences. While the medical community has gained insight into the …
devastating consequences. While the medical community has gained insight into the …
Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: systematic review
Background Accurate seroprevalence estimates of SARS-CoV-2 in different populations
could clarify the extent to which current testing strategies are identifying all active infection …
could clarify the extent to which current testing strategies are identifying all active infection …
Nationally representative results on SARS-CoV-2 seroprevalence and testing in Germany at the end of 2020
H Neuhauser, AS Rosario, H Butschalowsky, S Haller… - Scientific reports, 2022 - nature.com
Abstract Pre-vaccine SARS-CoV-2 seroprevalence data from Germany are scarce outside
hotspots, and socioeconomic disparities remained largely unexplored. The nationwide …
hotspots, and socioeconomic disparities remained largely unexplored. The nationwide …
Robust neutralizing antibody levels detected after either SARS-CoV-2 vaccination or one year after infection
Humoral immunity after infection or after vaccination against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has been attributed a key part in mitigating the …
syndrome coronavirus 2 (SARS-CoV-2) has been attributed a key part in mitigating the …
The role of risk communication in public health interventions. An analysis of risk communication for a community quarantine in Germany to curb the SARS-CoV-2 …
J Scholz, W Wetzker, A Licht, R Heintzmann… - PloS one, 2021 - journals.plos.org
Background Separating ill or possibly infectious people from their healthy community is one
of the core principles of non-pharmaceutical interventions. However, there is scarce …
of the core principles of non-pharmaceutical interventions. However, there is scarce …
Public health risk communication through the lens of a quarantined community: Insights from a coronavirus hotspot in Germany
A Licht, W Wetzker, J Scholz, A Scherag, S Weis… - Plos one, 2023 - journals.plos.org
Background Quarantine is one of the most effective interventions to contain an infectious
disease outbreak, yet it is one of the most disruptive. We investigated the quarantine of an …
disease outbreak, yet it is one of the most disruptive. We investigated the quarantine of an …
Seroepidemiologische Studien zu SARS-CoV-2 in Stichproben der Allgemeinbevölkerung und bei Blutspenderinnen und Blutspendern in Deutschland–Ergebnisse …
H Neuhauser, N Buttmann-Schweiger, U Ellert, J Fiebig… - 2021 - edoc.rki.de
Seroepidemiologische Studien geben Aufschluss über den Bevölkerungsanteil, der bereits
eine SARS-CoV-2-Infektion durchgemacht hat und schließen dabei auch nicht erkannte …
eine SARS-CoV-2-Infektion durchgemacht hat und schließen dabei auch nicht erkannte …
Prospective surveillance study in a 1,400‐bed university hospital: COVID‐19 exposure at home was the main risk factor for SARS‐CoV‐2 point seroprevalence among …
C Bahrs, A Kimmig, S Weis, J Ankert… - Transboundary and …, 2022 - Wiley Online Library
The Co‐HCW study is a prospective cohort study among hospital staff, including healthcare
workers (HCWs) and administration staff, at the Jena University Hospital (JUH), Germany …
workers (HCWs) and administration staff, at the Jena University Hospital (JUH), Germany …
Non-patient-related SARS-CoV-2 exposure from colleagues and household members poses the highest infection risk for hospital employees in a German university …
Abstract Purpose The Co-HCW study is a prospective, longitudinal, single-center
observational study that aims to assess the SARS-CoV-2 seroprevalence and infection …
observational study that aims to assess the SARS-CoV-2 seroprevalence and infection …
One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis
A Jaudszus, M Pavlova, M Rasche, M Baier… - BMC Pulmonary …, 2022 - Springer
Abstract Background In Germany, the first case of coronavirus disease 2019 (COVID-19)
was registered on 28 January 2020. By February 2021, the third wave of the pandemic …
was registered on 28 January 2020. By February 2021, the third wave of the pandemic …